Updates from around the Mölnlycke world

Gothenburg, Sweden. 28 January 2025. “This is a significant milestone in Mölnlycke’s commitment to halving Scope 1 and 2 greenhouse gas emissions by 2030” said Caterina Camerani, VP Sustainability at Mölnlycke. “It propels us towards our vision of building a sustainable healthcare manufacturing ecosystem.”   A major enabler in reaching the goal was signing two virtual Power Purchase Agreements (vPPAs) for the regions where the company has the highest manufacturing footprint. To cover electricity consumption for the sites in the European Union, Mölnlycke signed a long-term vPPA committing to purchasing renewable electricity generated in Mutkalampi, the largest wind farm in Finland. The three manufacturing plants in Malaysia will handle their renewable electricity needs through a similar vPPA from a newly established solar power plant in Bukit Kayu Hitam, Malaysia. In addition, Mölnlycke continues to invest in on-site generation of solar energy with manufacturing sites in Malaysia and the UK having completed the installation of rooftop solar panels and the installation on factories in Thailand ongoing. The remaining electricity consumption needs for the established manufacturing sites in Thailand, the UK and the US, as well as the newly established plant in the Kingdom of Saudi Arabia are met through Renewable Energy Certificates (RECs). As stated in the near-term goal validated by SBTi, Mölnlycke will continue active sourcing of renewable electricity through 2030.   For more information, please contact:  [Contact card] Sofia Lindqvist

Gothenburg, Sweden. 8 January 2025. Mölnlycke Health Care, a world-leading MedTech company specialising in wound care solutions, announced today an investment of USD 8 million in Siren. The healthcare tech company Siren is on a mission to help reduce the risk of diabetic foot ulcers by early detection of potential injuries through temperature-sensing textile technology. About 830 million people around the world suffer from diabetes1, living with the risk of diabetic foot ulcers (DFU) and amputation. Siren has developed “the Siren sock” as well as remote patient monitoring clinical teams, creating a service ecosystem for patients at risk of DFU. The system has been clinically proven to reduce the risk of ulcers by up to 68%2 and amputations by 83%2. This means less suffering for patients and is estimated to lower the cost of care by approximately USD 10,000 per patient annually. In addition, the workload for physicians is reduced, which is increasingly important in the pressurised healthcare environment. “Our strategic investment in Siren reflects our commitment to integrating into digital ecosystems and pioneering innovative digital solutions that revolutionise healthcare delivery,” says Zlatko Rihter, CEO of Mölnlycke and continues “Helping to prevent wounds from occurring is also in line with Mölnlycke’s Wound Care mission to ‘help free patients from the burden of wounds’ and our ambition to further support healthcare in the post-acute segment.” “We’re excited to team up with Mölnlycke to tackle diabetic foot ulcers at their earliest stages”, says Ran Ma, co-founder and CEO of Siren. “By investing in preventive technologies like ours, Mölnlycke is demonstrating real vision and leadership in helping patients avoid the debilitating consequences of diabetic foot ulcers. Their investment sends a clear message that prevention matters. By catching issues before they escalate, we can help patients stay healthy and independent, reduce unnecessary procedures, and ultimately make a real difference in their lives.” This investment marks a significant step forward in the fight against diabetic foot ulcers, combining Mölnlycke’s expertise in wound care with Siren’s innovative technology. Together, the aim is to enhance patient outcomes, reduce healthcare costs and alleviate the burden on healthcare providers. For more information, please contact:  [Contact card] Sofia Lindqvist About Siren Siren is at the forefront of smart wound care technology, specialising in innovative solutions that revolutionise the way diabetic foot ulcers and other wound types are prevented and managed. Through its unique blend of technology, clinical evidence, and patient-centered design, Siren is dedicated to enhancing quality of life and reducing healthcare costs for patients worldwide. www.siren.care About Siren’s solution Siren has developed a technology for integrating sensors into a yarn that can be converted into textiles. The technology has been incorporated into temperature-sensing socks for monitoring diabetic patients for early signs of DFU by detecting hot-spots on the feet. The socks are fitted with Bluetooth connectivity, battery and an accelerometer tracking patient movement.  Besides the physical socks, Siren has also established a remote patient monitoring team of home-based wound care nurses. The sock continuously tracks patients and sends alerts to the remote care team on any signs of hot spots development and allows for an early triaging and intervention, enabling the Siren to minimize false positives and reduce physician workload. References WHO, https://www.who.int/health-topics/diabetes Shih et al., Effectiveness of a Continuous Remote Temperature Monitoring Program to Reduce Foot Ulcers and Amputations: Multicenter Postmarket Registry Study, JMIR Diabetes 2024    

Gothenburg, Sweden. 26 November 2024. The award ceremony was held on 25 November at the Nobel Prize Museum in Stockholm, Sweden where Susanne Larsson, CFO & EVP IT, Digital Enablement, GBS and Indirect Procurement and Caterina Camerani, VP Sustainability at Mölnlycke, accepted the award on behalf of the company. “Our ambition is to transform our business to become a global leader in sustainable healthcare. This award is proof that we are on the right track. We are dedicated to equipping our customers with innovative and sustainable healthcare solutions – for our customers, our employees, our communities and the planet,” says Caterina Camerani, VP Sustainability at Mölnlycke. Mölnlycke ProcedurePak® trays enhance efficiency¹ and help decarbonise healthcare by reducing waste and greenhouse gas (GHG) emissions². ProcedurePak® offers a sterile tray with all necessary components, reducing setup time in the Operating Room by up to 40%¹, and packaging waste by up to 90%² compared to procedures conducted with single-packed products. In one tray package, hospitals can simplify procurement and help ensure patient safety³. The streamlined workflow decreases manual tasks, alleviating stress and freeing up more time for healthcare professionals to focus on patient care. Digital tools like the Mölnlycke Portal and CO2 calculator together with ProcedurePak® Value Report allow hospitals to quantify reductions in waste and GHG emissions, aligning with both sustainability and operational objectives. The judging panel commented: “In recognition of outstanding contributions to sustainability and innovation, this year’s Swedish award celebrates a project that has significantly enhanced operational efficiency while reducing environmental impact. Their commitment to sustainability is further demonstrated by reducing waste, CO2 emissions and preparation time while ensuring patient safety.” For more information, please contact: [Contact card] Sofia Lindqvist About the Cagemini Nordic Sustainability Tech Award The Capgemini Nordic Sustainability Tech Award celebrates organisations across the Nordic region creating innovative technology solutions for a sustainable future. The urgency of the global climate crisis demands ground-breaking technology and IT service innovations that scale across industries. The Nordic Sustainability Tech Award celebrates the inspirational tech pioneers pushing the boundaries of sustainable IT and their role in limiting the environmental and social impact of climate change. References 1 Greiling. A multinational case study to evaluate and quantify time-saving by using custom procedure trays for operation room efficiency. (poster from 2010). 2 Assessing the carbon and waste benefits of moving to Procedure Packs at Royal Liverpool and Broadgreen University Hospitals, NHS Trust, 2011. 3 Optimisation of perioperative procedural factors to reduce the risk of surgical site infection in patients undergoing surgery: a systematic review Key findings P. Calò , F. Catena, D. Corsaro, L. Costantini, F. Falez, B. Moretti, V. Parrinello, E. Romanini, A. Spinarelli, G. Vaccaro, F. Venneri. Discov Health Systems 2, 6 (2023). https://doi.org/10.1007/s44250-023-00019-9.